Perceptive Advisors’s Madrigal Pharmaceuticals MDGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-46,500
| Closed | -$15.4M | – | 99 |
|
|
2025
Q1 | $15.4M | Buy |
+46,500
| New | +$15.3M | 0.55% | 41 |
|
|
2024
Q3 | – | Sell |
-264,600
| Closed | -$74.1M | – | 118 |
|
|
2024
Q2 | $74.1M | Sell |
264,600
-165,353
| -38% | -$39.4M | 1.79% | 13 |
|
|
2024
Q1 | $115M | Buy |
429,953
+278,802
| +184% | +$65.7M | 2.02% | 13 |
|
|
2023
Q4 | $35M | Buy |
151,151
+26,514
| +21% | +$4.64M | 0.78% | 40 |
|
|
2023
Q3 | $18.2M | Sell |
124,637
-178,350
| -59% | -$33.6M | 0.61% | 45 |
|
|
2023
Q2 | $70M | Sell |
302,987
-347,575
| -53% | -$94.1M | 2.03% | 15 |
|
|
2023
Q1 | $158M | Sell |
650,562
-81,370
| -11% | -$22.2M | 4.66% | 5 |
|
|
2022
Q4 | $212M | Buy |
731,932
+400,909
| +121% | +$39.2M | 6.12% | 3 |
|
|
2022
Q3 | $21.5M | Sell |
331,023
-36,478
| -10% | -$2.53M | 0.63% | 43 |
|
|
2022
Q2 | $26.3M | Buy |
367,501
+89,215
| +32% | +$6.56M | 0.83% | 29 |
|
|
2022
Q1 | $27.3M | Buy |
278,286
+191,886
| +222% | +$16.2M | 0.55% | 45 |
|
|
2021
Q4 | $7.32M | Buy |
+86,400
| New | +$7.1M | 0.11% | 105 |
|
|
2018
Q4 | – | Sell |
-2,213
| Closed | -$474K | – | 117 |
|
|
2018
Q3 | $474K | Sell |
2,213
-30,000
| -93% | -$7.53M | 0.01% | 105 |
|
|
2018
Q2 | $9.01M | Sell |
32,213
-110,309
| -77% | -$19.4M | 0.24% | 61 |
|
|
2018
Q1 | $16.6M | Sell |
142,522
-46,371
| -25% | -$5.72M | 0.47% | 50 |
|
|
2017
Q4 | $17.3M | Buy |
+188,893
| New | +$10.8M | 0.57% | 47 |
|
|
2013
Q4 | – | Sell |
-68,035
| Closed | -$15M | – | 131 |
|
|
2013
Q3 | $15M | Sell |
68,035
-8,915
| -12% | -$1.9M | 1.32% | 18 |
|
|
2013
Q2 | $13.4M | Buy |
+76,950
| New | +$20.1M | 1.5% | 16 |
|
Other funds holding MDGL
PC
RI
BBA
ACA
